Clinical Trial Update: Preventing Recurrent UTI With Vaginal Estrogen [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating vaginal estrogen to prevent recurrent urinary tract infections has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystitis Recurrent
• Urinary Tract Infection

Drugs mentioned

• Vaginal estrogen

Snippet

Sponsor: Johns Hopkins University | Conditions: Recurrent Urinary Tract Infection, Urinary Tract Infections | Phase 4 | Status: COMPLETED | Results posted: 2026-03-05